| ［1］ |
Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence［J］. J Invest Dermatol, 2013,133（2）:377⁃385. doi: 10.1038/jid. 2012.339.
|
| ［2］ |
Gui XY, Yu XL, Jin HZ, et al. Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital⁃based cross⁃sectional study［J］. J Diabetes Investig, 2018,9（1）:39⁃43. doi: 10.1111/jdi.12663.
|
| ［3］ |
Hsu S, Green LJ, Lebwohl MG, et al. Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials［J］. Br J Dermatol, 2020,182（4）:880⁃888. doi: 10.1111/bjd.18327.
|
| ［4］ |
Owczarczyk⁃Saczonek A, Purzycka⁃Bohdan D, Nedoszytko B, et al. Pathogenesis of psoriasis in the "omic" era. Part Ⅲ. Metabolic disorders, metabolomics, nutrigenomics in psoriasis［J］. Postepy Dermatol Alergol, 2020,37（4）:452⁃467. doi: 10.5114/ada.2020.98284.
|
| ［5］ |
Teklu M, Parel PM, Mehta NN. Psoriasis and cardiometabolic diseases: the impact of inflammation on vascular health［J］. Psoriasis （Auckl）, 2021,11:99⁃108. doi: 10.2147/PTT.S320016.
|
| ［6］ |
Peralta C, Hamid P, Batool H, et al. Psoriasis and metabolic syndrome: comorbidities and environmental and therapeutic implications［J］. Cureus, 2019,11（12）:e6369. doi: 10.7759/cureus.6369.
|
| ［7］ |
Kovács D, Fazekas F, Oláh A, et al. Adipokines in the skin and in dermatological diseases［J］. Int J Mol Sci, 2020,21（23）:9048. doi: 10.3390/ijms21239048.
|
| ［8］ |
Hu D, Yang Y, Peng DQ. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 （PCSK9） in statin⁃naive patients with coronary artery disease［J］. Int J Cardiol, 2017,227:61⁃65. doi: 10.1016/j.ijcard. 2016.11.064.
|
| ［9］ |
Luan C, Chen X, Zhu Y, et al. Potentiation of psoriasis⁃like inflammation by PCSK9［J］. J Invest Dermatol, 2019,139（4）:859⁃867. doi: 10.1016/j.jid.2018.07.046.
|
| ［10］ |
Zhang R, Wang YH, Shi X, et al. Sortilin regulates keratinocyte proliferation and apoptosis through the PI3K⁃AKT signaling pathway［J］. Life Sci, 2021,278:119630. doi: 10.1016/j.lfs.2021. 119630.
|
| ［11］ |
Garshick MS, Baumer Y, Dey AK, et al. Characterization of PCSK9 in the blood and skin of psoriasis［J］. J Invest Dermatol, 2021,141（2）:308⁃315. doi: 10.1016/j.jid.2020.05.115.
|
| ［12］ |
Gao Y, Lu J, Bao X, et al. Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation［J］. Exp Biol Med （Maywood）, 2021,246（11）:1253⁃1262. doi: 10.1177/1535370221993424.
|
| ［13］ |
Shao S, Chen J, Swindell WR, et al. Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris［J］. JCI Insight, 2021,6（20）:e151911 ［pii］. doi: 10.1172/jci.insight.151911.
|
| ［14］ |
Singh R, Chen YL, Ng SW, et al. Phospholipase activity of acyloxyacyl hydrolase induces IL⁃22⁃producing CD1a⁃autoreactive T cells in individuals with psoriasis［J］. Eur J Immunol, 2022,52（3）:511⁃524. doi: 10.1002/eji.202149485.
|
| ［15］ |
Sparks CE, Sparks RP, Sparks JD. The enigmatic role of sortilin in lipoprotein metabolism［J］. Curr Opin Lipidol, 2015,26（6）:598⁃600. doi: 10.1097/MOL.0000000000000244.
|
| ［16］ |
Nowowiejska J, Baran A, Krahel JA, et al. Serum cholesteryl ester transfer protein （CETP） and sortilin （SORT） in patients with psoriasis with relation to systemic treatment［J］. Metabolites, 2022,12（4）:340. doi: 10.3390/metabo12040340.
|
| ［17］ |
Duvetorp A, Olsen RS, Nyström H, et al. Expression of low⁃density lipoprotein⁃related receptors 5 and 6 （LRP5/6） in psoriasis skin［J］. Exp Dermatol, 2017,26（11）:1033⁃1038. doi: 10.1111/exd.13362.
|
| ［18］ |
Pasmatzi E, Papadionysiou C, Monastirli A, et al. Galectin 1 in dermatology: current knowledge and perspectives［J］. Acta Dermatovenerol Alp Pannonica Adriat, 2019,28（1）:27⁃31.
|
| ［19］ |
Pasmatzi E, Papadionysiou C, Monastirli A, et al. Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives［J］. An Bras Dermatol, 2019,94（3）:348⁃354. doi: 10.1590/abd1806⁃4841.20198426.
|
| ［20］ |
Corrêa MP, Correia⁃Silva RD, Sasso G, et al. Expression pattern and immunoregulatory roles of galectin⁃1 and galectin⁃3 in atopic dermatitis and psoriasis［J］. Inflammation, 2022,45（3）:1133⁃1145. doi: 10.1007/s10753⁃021⁃01608⁃7.
|
| ［21］ |
Shih CM, Huang CY, Wang KH, et al. Oxidized low⁃density lipoprotein⁃deteriorated psoriasis is associated with the upregulation of lox⁃1 receptor and IL⁃23 expression in vivo and in vitro［J］. Int J Mol Sci, 2018,19（9）:2610. doi: 10.3390/ijms19092610.
|
| ［22］ |
Wang H, Yang G, Zhang Q, et al. Apremilast ameliorates ox⁃LDL⁃induced endothelial dysfunction mediated by KLF6［J］. Aging （Albany NY）, 2020,12（19）:19012⁃19021. doi: 10.18632/aging. 103665.
|
| ［23］ |
Gupta M, Mahajan VK, Mehta KS, et al. Peroxisome proliferator⁃activated receptors （PPARs） and PPAR agonists: the 'future' in dermatology therapeutics?［J］. Arch Dermatol Res, 2015,307（9）:767⁃780. doi: 10.1007/s00403⁃015⁃1571⁃1.
|
| ［24］ |
Sobolev V, Nesterova A, Soboleva A, et al. Analysis of PPARγ signaling activity in psoriasis［J］. Int J Mol Sci, 2021,22（16）:8603. doi: 10.3390/ijms22168603.
|
| ［25］ |
Blunder S, Pavel P, Minzaghi D, et al. PPARdelta in affected atopic dermatitis and psoriasis: a possible role in metabolic reprograming［J］. Int J Mol Sci, 2021,22（14）:7354. doi: 10. 3390/ijms22147354.
|
| ［26］ |
Hao Y, Zhu YJ, Zou S, et al. Metabolic syndrome and psoriasis: mechanisms and future directions［J］. Front Immunol, 2021,12:711060. doi: 10.3389/fimmu.2021.711060.
|
| ［27］ |
Oh YJ, Lim HK, Choi JH, et al. Serum leptin and adiponectin levels in Korean patients with psoriasis［J］. J Korean Med Sci, 2014,29（5）:729⁃734. doi: 10.3346/jkms.2014.29.5.729.
|
| ［28］ |
Wang Y, Huo J, Zhang D, et al. Chemerin/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS⁃sirt1⁃NF⁃κB signaling［J］. J Cell Biochem, 2019,120（4）:6459⁃6470. doi: 10.1002/jcb.27936.
|
| ［29］ |
Zou Q, Si J, Guo Y, et al. Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta⁃analysis［J］. J Int Med Res, 2021,49（3）:300060521100 2381. doi: 10.1177/03000605211002381.
|
| ［30］ |
Wang HM, Wu C, Jiang YY, et al. Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model［J］. Nutr Metab （Lond）, 2020, 17:5. doi: 10.1186/s12986⁃019⁃0423⁃y.
|
| ［31］ |
Shehata WA, Basha MA, Gayed IM, et al. Relationship between disease severity and fetuin⁃A levels in patients with psoriasis［J］. Indian J Dermatol Venereol Leprol, 2020,86（5）:586⁃588. doi: 10.4103/ijdvl.IJDVL_355_19.
|
| ［32］ |
Aizawa N, Ishiuji Y, Tominaga M, et al. Relationship between the degrees of itch and serum lipocalin⁃2 levels in patients with psoriasis［J］. J Immunol Res, 2019,2019:8171373. doi: 10.1155/2019/8171373.
|
| ［33］ |
Chekol Abebe E, Tilahun Muche Z, Behaile T/Mariam A, et al. Role of fetuin⁃A in the pathogenesis of psoriasis and its potential clinical applications［J］. Clin Cosmet Investig Dermatol, 2022,15:595⁃607. doi: 10.2147/CCID.S356801.
|
| ［34］ |
胡煜, 栾超, 练霓, 等. 银屑病患者血浆中前蛋白转化酶枯草溶菌素9的表达及对外周血CD4+ T细胞活化的影响［J］. 中华皮肤科杂志, 2019,52（2）:90⁃93. doi: 10.3760/cma.j.issn.0412⁃4030.2019.02.004.
|
